| CD39 and CD73 in immunity and inflammation L Antonioli, P Pacher, ES Vizi, G Haskó Trends in molecular medicine 19 (6), 355-367, 2013 | 1228 | 2013 |
| Immunity, inflammation and cancer: a leading role for adenosine L Antonioli, C Blandizzi, P Pacher, G Haskó Nature Reviews Cancer 13 (12), 842-857, 2013 | 804 | 2013 |
| Anti-CD73 in cancer immunotherapy: awakening new opportunities L Antonioli, GG Yegutkin, P Pacher, C Blandizzi, G Haskó Trends in cancer 2 (2), 95-109, 2016 | 235 | 2016 |
| Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? C Pellegrini, L Antonioli, R Colucci, C Blandizzi, M Fornai Acta neuropathologica 136, 345-361, 2018 | 215 | 2018 |
| Canonical and non-canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation C Pellegrini, L Antonioli, G Lopez-Castejon, C Blandizzi, M Fornai Frontiers in immunology 8, 237490, 2017 | 203 | 2017 |
| Adenosine and inflammation: what's new on the horizon? L Antonioli, B Csóka, M Fornai, R Colucci, E Kokai, C Blandizzi, G Haskó Drug Discovery Today 19 (8), 1051-1068, 2014 | 187 | 2014 |
| Adenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations L Antonioli, C Blandizzi, B Csóka, P Pacher, G Haskó Nature reviews endocrinology 11 (4), 228-241, 2015 | 182 | 2015 |
| Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders L Antonioli, R Colucci, C La Motta, M Tuccori, O Awwad, F Da Settimo, ... Current drug targets 13 (6), 842-862, 2012 | 173 | 2012 |
| Adenosine signaling and the immune system: When a lot could be too much L Antonioli, M Fornai, C Blandizzi, P Pacher, G Haskó Immunology letters 205, 9-15, 2019 | 164 | 2019 |
| Crohn’s disease and ulcerative colitis show unique cytokine profiles ZH Nemeth, DA Bogdanovski, P Barratt-Stopper, SR Paglinco, L Antonioli, ... Cureus 9 (4), 2017 | 161 | 2017 |
| Development of an acrylate derivative targeting the NLRP3 inflammasome for the treatment of inflammatory bowel disease M Cocco, C Pellegrini, H Martínez-Banaclocha, M Giorgis, E Marini, ... Journal of Medicinal Chemistry 60 (9), 3656-3671, 2017 | 146 | 2017 |
| Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review M Tuccori, A Testi, L Antonioli, M Fornai, S Montagnani, N Ghisu, ... Clinical therapeutics 31, 1426-1453, 2009 | 141 | 2009 |
| Inhibition of adenosine deaminase attenuates inflammation in experimental colitis L Antonioli, M Fornai, R Colucci, N Ghisu, F Da Settimo, G Natale, ... Journal of Pharmacology and Experimental Therapeutics 322 (2), 435-442, 2007 | 137 | 2007 |
| The purinergic system as a pharmacological target for the treatment of immune-mediated inflammatory diseases L Antonioli, C Blandizzi, P Pacher, G Haskó Pharmacological reviews 71 (3), 345-382, 2019 | 134 | 2019 |
| Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications L Antonioli, M Fornai, R Colucci, N Ghisu, M Tuccori, M Del Tacca, ... Pharmacology & therapeutics 120 (3), 233-253, 2008 | 133 | 2008 |
| Histochemical detection of collagen fibers by sirius red/fast green is more sensitive than van gieson or sirius red alone in normal and inflamed rat colon C Segnani, C Ippolito, L Antonioli, C Pellegrini, C Blandizzi, A Dolfi, ... PloS one 10 (12), e0144630, 2015 | 131 | 2015 |
| Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing B Csóka, ZH Németh, G Törő, M Idzko, A Zech, B Koscsó, Z Spolarics, ... The FASEB Journal 29 (9), 3626, 2015 | 126 | 2015 |
| Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress A Virdis, R Colucci, M Fornai, C Blandizzi, E Duranti, S Pinto, N Bernardini, ... Journal of Pharmacology and experimental therapeutics 312 (3), 945-953, 2005 | 114 | 2005 |
| Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? C Pellegrini, L Antonioli, V Calderone, R Colucci, M Fornai, C Blandizzi Progress in neurobiology 191, 101806, 2020 | 109 | 2020 |
| NKG2A and COVID-19: another brick in the wall L Antonioli, M Fornai, C Pellegrini, C Blandizzi Cellular & molecular immunology 17 (6), 672-674, 2020 | 101 | 2020 |
Corrado Blandizzi, MDProfessore di Farmacologia, Università di PisaVerified email at med.unipi.it
